Literature DB >> 11262658

Vitrectomy in the management of uveitis.

E H Bovey1, C P Herbort.   

Abstract

OBJECTIVE: To review the indications for vitrectomy in uveitis cases. PATIENTS AND METHODS: Charts of patients seen at the uveitis clinic of the Jules Gonin Eye Hospital from January 1993 to August 1998 and who had undergone vitrectomy were reviewed. Patients with infectious uveitis occurring within three months after intraocular cataract surgery were excluded. The types of uveitis were recorded and indications for vitrectomy were analyzed.
RESULTS: A total of 630 patients were examined at the uveitis clinic. Fifty-one of these patients (51 eyes, 8.1%) were referred for vitrectomy and were included in this study. Vitrectomy was performed for three reasons: 1) to treat the complications of uveitis (90%), including vitreous opacification in 35 eyes (69%), retinal detachment in seven eyes (14%), epimacular membrane in seven eyes (14%), and dense opacification of the posterior capsule after cataract surgery in six eyes (12%)(the mean delay between uveitis and vitrectomy in this group was 8.4 years); 2) for diagnostic purposes in 19 eyes (37%); and 3) to remove confined infectious foci in 16 eyes (31%) and allow a thorough intraocular distribution of antibiotics. Visual acuity improved in 41 patients (80.4%), remained unchanged in three (5.8%), and decreased in seven (13.7%) because of secondary or persistent retinal detachment or cystoid macular edema.
CONCLUSION: Vitrectomy was indicated to treat the complications of uveitis, to provide vitreous for diagnostic purposes, and to allow a better diffusion of intraocular antibiotics. Long-standing uveitis did not seem to be influenced by vitrectomy.

Entities:  

Mesh:

Year:  2000        PMID: 11262658     DOI: 10.1076/ocii.8.4.285.6456

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  9 in total

Review 1.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

Review 2.  Vitreoretinal surgery in the management of infectious and non-infectious uveitis - a narrative review.

Authors:  Jia-Horung Hung; Narsing A Rao; Wei-Chun Chiu; Shwu-Jiuan Sheu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-12       Impact factor: 3.535

3.  Clinical Features of Japanese Patients with Ocular Inflammation and Their Surgical Procedures Over the Course of 20 Years.

Authors:  Nanae Takai; Takatoshi Kobayashi; Teruyo Kida; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2020-09-24

4.  Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.

Authors:  K-H Sonoda; H Enaida; A Ueno; T Nakamura; Y-I Kawano; T Kubota; T Sakamoto; T Ishibashi
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

Review 5.  [Therapeutic vitrectomy in uveitis: current status and recommendations].

Authors:  M D Becker; N Harsch; M Zierhut; J L Davis; F G Holz
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

6.  Evaluation of microincision vitrectomy surgery using wide-viewing system for complications with ocular sarcoidosis.

Authors:  Kei Takayama; Atsushi Tanaka; Masanori Shibata; Tadashi Muraoka; Sho Ishikawa; Kouzo Harimoto; Masaru Takeuchi
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

Review 7.  Surgical management in patient with uveitis.

Authors:  Somasheila I Murthy; Rajeev Reddy Pappuru; K Madhavi Latha; Sripathi Kamat; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2013-06       Impact factor: 1.848

8.  Value of optical coherence tomography in the detection of macular pathology before the removal of silicone oil.

Authors:  Mohammad Ahmad Rashad; Ahmed Abdel Aliem Mohamed; Asmaa Ismail Ahmed
Journal:  Clin Ophthalmol       Date:  2016-01-19

Review 9.  Pars plana vitrectomy in uveitis in the era of microincision vitreous surgery.

Authors:  Reema Bansal; Mohit Dogra; Rohan Chawla; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.